Argitalpenak (115) ANA ISABEL TORRES SUÁREZ argitalpenak

2024

  1. Assessment of In Vitro Release Testing Methods for Colloidal Drug Carriers: The Lack of Standardized Protocols

    Pharmaceutics, Vol. 16, Núm. 1

  2. Correction to: Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release (Drug Delivery and Translational Research, (2024), 14, 4, (959-969), 10.1007/s13346-023-01444-2)

    Drug Delivery and Translational Research

  3. Development and Characterization of a Microemulsion Containing a Cannabidiol Oil and a Hydrophilic Extract from Sambucus ebulus for Topical Administration

    Pharmaceutics, Vol. 16, Núm. 6

  4. Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release

    Drug Delivery and Translational Research, Vol. 14, Núm. 4, pp. 959-969

2023

  1. An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines

    Advanced Drug Delivery Reviews, Vol. 196

  2. Cannabidiol (CBD) use in breast cancer chemotherapy

    Medicinal Usage of Cannabis and Cannabinoids (Elsevier), pp. 373-383

  3. Capacitación de alumnos de pregrado en la generación de contenidos divulgativos de Farmacia y Tecnología Farmacéutica para su difusión en entornos virtuales

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  4. Design of dosage forms: influences of anatomy and administration routes

    Dosage Forms, Formulation Developments and Regulations: Recent and Future Trends in Pharmaceutics, Volume 1 (Elsevier), pp. 183-221

  5. Diseño de formulaciones para terapia combinada frente alglioblastoma

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  6. Hidrogeles para la administración local de antibióticos: elaboración, caracterización y estudios de toxicidad In Ovo

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  7. In vitro screening of the Blood-Brain Barrier targetingcapacity of small-sized lipid nanocapsules decorated with cannabinoids

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  8. Nanopartículas de albúmina cargadas con cannabidiol: estudio de la influencia en el agente reticulante

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  9. XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones ed. lit.

    Sociedad Española de Farmacia Industrial y Galénica

2022

  1. Active targeted nanoformulations via folate receptors: State of the art and future perspectives

    Pharmaceutics, Vol. 14, Núm. 1

  2. Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic

    Cancers, Vol. 14, Núm. 5

  3. Administración de medicamentos por vía pulmonar: manejo de inhaladores

    Lo que debes saber sobre medicamentos y salud (Grupo Planeta), pp. 191-207

  4. Aplicación de las TIC en asignaturas teórico-prácticas del grado en Farmacia: tecnología farmacéutica y biofarmacia y farmacocinética

    Jornada «Aprendizaje Eficaz con TIC en la UCM» (Universidad Complutense de Madrid), pp. 43-53

  5. Current status of nanomedicine for breast cancer treatment

    Targeted Nanomedicine for Breast Cancer Therapy (Elsevier), pp. 65-110

  6. Embolization therapy with microspheres for the treatment of liver cancer: State-of-the-art of clinical translation

    Acta Biomaterialia, Vol. 149, pp. 1-15

  7. Limitations and challenges in the stability of cysteamine eye drop compounded formulations

    Pharmaceuticals, Vol. 15, Núm. 1